ENVALITH

MFS,Inc. 1Q Earnings Flash

INVASE doubled revenue and MogeCheck improved cost efficiency, lifting the company to an operating profit. Recovery in property-level profitability is now the key to delivering the full-year plan.

PublishedNovember 12, 2026 at 17:13 GMT+9

Key Positives From The 1Q Results

SG&A fell 19.9% YoY, and operating income came in at JPY 72M, swinging from a loss in the year-ago quarter. Selective ad spending and SEO gains allowed MogeCheck to post a 31.3% margin despite lower revenue. INVASE doubled revenue on higher contract volumes. The division of roles between the two pillars is now clear.

  • SG&A Discipline
    : SG&A fell to JPY 363M (-19.9% YoY). The JPY 90M cut in SG&A more than offset the JPY 7M decline in gross profit, driving the swing to an operating profit.
  • MogeCheck Profitability
    : Segment profit reached JPY 83M (prior-year 1Q: JPY -7M), a 31.3% margin. SEO-driven gains in customer acquisition efficiency are shifting the business toward a revenue model less dependent on advertising.
  • INVASE Top-Line Growth
    : Revenue reached JPY 2,224M (+102.7% YoY). Contracts rose to 187 (+61.2% YoY) and cumulative members to 69,430 (+28.0% YoY), broadening the business base.
  • Inventory Reduction and Deleveraging
    : Real estate for sale fell JPY 347M vs. the prior FY-end. Cash and deposits rose JPY 296M and short-term borrowings fell JPY 192M, reflecting progress on both monetization and debt repayment.
  • Share Buyback
    : The board approved a buyback of up to 400,000 shares / JPY 100M to fund stock-based compensation. The move signals attention to dilution from equity compensation.

Key Concerns From The 1Q Results

INVASE's share of revenue rose to 89.3% (our estimate), and gross profit margin fell 14.0pt YoY to 17.5%. INVASE's segment loss widened despite higher revenue. Profitability management in the property trading business therefore drives volatility in consolidated earnings. MogeCheck's profit growth came from cost cuts, with no sign yet of a top-line recovery.

  • Wider INVASE Loss
    : The segment loss widened to JPY -10M from JPY -2M a year earlier. Price trends for high-end condominiums in certain areas eroded the profitability of properties held.
  • Gross Margin Compression
    : Gross profit margin was 17.5% (prior-year 1Q: 31.5%). The higher mix of property trading makes it harder for revenue growth to translate into profit.
  • MogeCheck User Decline
    : User registrations fell to 19,753 (-35.2% YoY). Financial institutions continued to curb online advertising, and segment revenue fell 14.2% YoY.
  • Rising Interest Expense
    : Interest expense rose to JPY 4,693K from JPY 679K a year earlier. In a rising-rate environment, the cost of debt-funded property acquisitions is becoming heavier.

Focus Areas / Items To Monitor Going Forward

  • INVASE Margin Recovery
    : Timing of a recovery in profitability on INVASE's property holdings. Also key is how high-end condominium prices affect inventory valuations and gains on sale. A return to segment profitability is a precondition for the full-year plan.
  • MogeCheck Referral Revenue
    : How the drop in MogeCheck registrations will affect future referral revenue. Also key is when management decides to pivot back to growth reinvestment as financial institutions restore ad budgets.
  • Earnings Trajectory
    : 1Q progress is 19.6% against the full-year operating income plan of JPY 371M. Investors need clarity on whether profits are again expected to be 2H-weighted, as in the prior year, and on the quarterly build-up path.
Discussion Points For Management
  • Scale of the properties held with deteriorated profitability, and the sales outlook for the JPY 981M of real estate for sale
  • Revisions to INVASE's property acquisition criteria, and policy on diversification by area and price band
  • Initiatives to restore MogeCheck user registrations, and criteria for redeploying advertising spend
  • Progress in realizing business synergies from the capital and business alliance with Zenkoku Hosho
  • Purpose of the JPY 30M increase in long-term loans to directors, and its relationship to stock-based compensation and the employee stock purchase program

Key Financial Highlights

ItemValueYoY
RevenueJPY 2,491M+76.9%
Cost of Goods SoldJPY 2,055M+113.1%
Gross ProfitJPY 436M-1.7%
└ Gross Profit Margin17.5%-14.0pt
SG&AJPY 363M-19.9%
Operating IncomeJPY 72MTurned profitable (prior-year 1Q: JPY -9M)
└ Operating Income Margin2.9%+3.6pt
Interest ExpenseJPY 4,693K+591.2%
Recurring ProfitJPY 70MTurned profitable (prior-year 1Q: JPY -7M)
Quarterly Net Income Attributable to Owners of Parent CompanyJPY 68MTurned profitable (prior-year 1Q: JPY -16M)
EPSJPY 6.74Turned profitable (prior-year 1Q: JPY -1.84)

Margins and YoY figures are our estimates. The higher mix of property trading pushed cost of goods sold up faster than revenue, leaving gross profit roughly flat YoY. The swing to an operating profit came from lower SG&A. Average shares outstanding rose to 10,198,900 (prior-year 1Q: 9,120,550), but EPS still turned positive.

Performance By Business Segment

INVASE doubled revenue, lifting its share of sales to 89.3% from 77.9% a year earlier (our estimate). MogeCheck, however, remains the company's profit engine.

Segment Performance Table

SegmentRevenueYoYOperating IncomeYoYMargin
MogeCheck BusinessJPY 266M-14.2%JPY 83MTurned Profitable31.3%
INVASE BusinessJPY 2,224M+102.7%JPY -10MLoss Widened-0.5%
TotalJPY 2,491M+76.9%JPY 72MTurned Profitable2.9%

YoY figures and margins are our estimates. Segment profit/loss is on an operating income basis.

Strong Performers
  • INVASE (Property Trading): Revenue rose 102.7% YoY. The trading-centric business model at subsidiary Condominium Asset Management has stabilized, and contracts rose to 187 (+61.2% YoY).
  • INVASE (Member Base): Expanded features in "INVASE" and "INVASE Pro," along with AI adoption, lifted cumulative members to 69,430 (+28.0% YoY). Members were acquired while ad spend stayed low.
  • MogeCheck (Profit): Efficient ad deployment and SEO gains held down costs. Segment profit reached JPY 83M, a swing to profitability.
Underperformers
  • MogeCheck (Revenue): Revenue fell 14.2% YoY as financial institutions continued to curb online advertising amid rising rates. Site traffic fell to 1,661,176 (-6.5% YoY), and user registrations fell to 19,753 (-35.2% YoY).
  • INVASE (Profit): The segment loss widened to JPY -10M. Price trends for high-end condominiums in certain areas reduced the profitability of some properties held.

Progress Versus Full-Year Guidance

Revenue progress stands at 24.3%, ahead of 16.9% a year earlier (1Q actual of JPY 1,407M against the prior FY total of JPY 8,317M). Operating income progress, however, is only 19.6%. Last fiscal year, the company posted a 1H cumulative operating loss of JPY -48M before building to JPY 222M for the full year. A recovery in INVASE's property-level profitability is a prerequisite for meeting the full-year plan.

ItemValue (1Q Cumulative)Full-Year ForecastProgress Rate
RevenueJPY 2,491MJPY 10,241M24.3%
Operating IncomeJPY 72MJPY 371M19.6%
Recurring ProfitJPY 70MJPY 369M19.0%
Net IncomeJPY 68MJPY 368M18.7%

Progress rates are our estimates.

  • 2H-Weighted Profits
    : Prior-year cumulative operating income/loss was JPY -9M at 1Q, JPY -48M at 1H, JPY 64M at 3Q and JPY 222M for the full year, with profits concentrated in 2H.

Changes To Guidance

Full-year guidance announced on 2026/08/13 is unchanged: revenue of JPY 10,241M, operating income of JPY 371M and net income of JPY 368M. 1Q delivered both revenue growth and an operating profit. From 2Q onward, margins on INVASE inventory sales will be the key to meeting the plan.

Commentary On Shareholder Returns

The annual dividend forecast is unchanged at JPY 0.00. On 2026/11/12, the board approved a share buyback of up to 400,000 shares (3.88% of total shares outstanding) or JPY 100M. Shares will be bought on the open market from 2026/11/13 to 2026/12/30. The purpose is to fund stock-based compensation for directors and employees. As a subsequent event, payment was completed on 2026/10/23 for 119,600 new shares issued as restricted stock compensation (JPY 320 per share; JPY 38M in total).

Financial Position

The equity ratio rose 5.0pt from the prior FY-end to 75.6%, and the company remains in a net cash position. Proceeds from sales of real estate for sale were used to repay borrowings, strengthening the balance sheet.

  • Key Figures
  • Leverage Metrics
ItemValueAdditional Information
Cash and DepositsJPY 2,202M+15.6% vs. prior FY-end
Real Estate for SaleJPY 981M-26.1% vs. prior FY-end
Total AssetsJPY 3,831M-4.4% vs. prior FY-end
Shareholders' EquityJPY 2,897M+2.4% vs. prior FY-end
Interest-Bearing DebtJPY 691M-24.1% vs. prior FY-end (our estimate)
└ Short-Term BorrowingsJPY 407M-32.1% vs. prior FY-end
└ Current Portion of Long-Term BorrowingsJPY 107MUnchanged from prior FY-end
└ Long-Term BorrowingsJPY 176M-13.2% vs. prior FY-end
Retained EarningsJPY -930M+JPY 68M vs. prior FY-end
EBITDAJPY 79MOperating income + depreciation of JPY 6,916K (our estimate)

Disclosures Released Alongside The Earnings Announcement

  • 2026/11/12
    Released supplementary materials for 1Q results and held the earnings briefing the same day (FY6/27 1Q Earnings Presentation Materials)
  • 2026/11/12
    Disclosed that directors and employees will buy company shares through the employee stock purchase program. The move signals alignment between management and shareholder interests (Purchase of Company Shares by Directors and Employees Through the Employee Stock Purchase Program)
  • 2026/11/12
    Approved a share buyback of up to 400,000 shares / JPY 100M. The buyback runs from November 13 to December 30 and will fund stock-based compensation (Notice Regarding Determination of Matters Related to Acquisition of Treasury Shares)

Major Announcements During The Quarter

  • 2026/08/14
    Advance disclosure on the corporate split of subsidiary Condominium Asset Management, which operates the INVASE business
  • 2026/09/25
    Approved the issuance of 119,600 new shares as restricted stock compensation for directors, employees and subsidiary directors
  • 2026/09/30
    Updated and released the growth potential document outlining the medium-term growth strategy and business plan
  • 2026/10/01
    Post-transaction disclosure on the corporate split of Condominium Asset Management
  • 2026/10/23
    Payment completed for new shares issued as restricted stock compensation; total issuance of JPY 38M

Large-Shareholding Filings / Material Proposals Over The Past Year

  • Rakuten Securities: 6.3%→5.3% (2026/07/31) - Temporary holding related to securities operations
  • Zenkoku Hosho: New→10.0% (2026/01/08) - Held for the purpose of a capital and business alliance with the issuer
Disclaimer

ENVALITH, INC. ("ENVALITH") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.

  • Purpose and Disclaimer Regarding Investment Decisions

    This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and ENVALITH and subject company shall not be involved in any such investment decisions.

  • Information Sources, Accuracy, and Disclaimer of Warranty

    This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. ENVALITH has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by ENVALITH using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, ENVALITH and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. ENVALITH and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.

  • Limitation of Liability

    ENVALITH and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.

  • Potential Conflicts of Interest

    ENVALITH may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.

  • No Obligation to Change or Update Content

    The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that ENVALITH is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.

  • Governing Language

    This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.

  • Copyright

    All rights (including copyrights) relating to this report belong to ENVALITH. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of ENVALITH is strictly prohibited.

  • Use for Other Investment Products

    Except where ENVALITH has provided prior written approval, the use of this report and the trademarks or trade names of ENVALITH or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.